Serum phospholipid alterations and their control by chlorophenoxyisobutyrate and betabenzalbutyrate in puromycin aminonucleoside induced nephrotic syndrome in the rat
- 8 May 1970
- journal article
- Published by Elsevier in Life Sciences
- Vol. 9 (9) , 523-534
- https://doi.org/10.1016/0024-3205(70)90353-x
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- The effects of p-chlorophenoxyisobutyrate on the turnover rate and distribution of thyroid hormone in the ratBiochemical Pharmacology, 1969
- Studies on the turnover of triglyceride and esterified cholesterol in subjects with the nephrotic syndromeJournal of Clinical Investigation, 1968
- Changes in the liver concentrations of the nicotinamide adenine dinucleotide coenzymes and in the activities of oxidoreductase enzymes following treatment of the rat with ethyl chlorophenoxyisobutyrate (Atromid-S)Biochemical Pharmacology, 1966
- NATURE OF THE HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN THE RATNature, 1965
- The effect of a single intravenous injection of aminonucleoside of Puromycin on the rat kidney: A light‐ and electron‐microscope studyThe Journal of Pathology and Bacteriology, 1962
- THE PHOSPHATIDES OF HUMAN PLASMA. II. ABNORMALITIES ENCOUNTERED IN THE NEPHROTIC SYNDROME*Journal of Clinical Investigation, 1961
- SERUM LIPID AND LIPOPROTEIN ALTERATIONS IN NEPHROSISJournal of Clinical Investigation, 1960
- MECHANISMS OF HYPERLIPEMIA IN EXPERIMENTAL NEPHROSIS*Journal of Clinical Investigation, 1959
- Plasma Lipid Interrelationships in Experimental Nephrosis1Journal of Clinical Investigation, 1957
- THE INTERRELATIONS OF SERUM LIPIDS IN PATIENTS WITH DISEASES OF THE KIDNEYS 1Journal of Clinical Investigation, 1943